-
18. Drug treatment damage via drug absorption to surface proteins
12:00 AM | November 30, -0001Author: Adeleke
antibodies, made to the now immunogenic drug epitope on carrier cell, bind, and complement-mediated lysis occurs.Continue reading
Archives
-
19. drug absorbs to cell (RBCs) surface proteins antibodies
12:00 AM | November 30, -0001Author: Adeleke
made to the now immunogenic drug epitope on carrier cell, bind, and complement-mediated lysis occurs.Continue reading
-
21. Pemphigus vulgaris is an example of
12:00 AM | November 30, -0001Author: Adeleke
a type 2 HSR where IgG against desmoglein proteins in desmosomesContinue reading
-
22. In type 3HS complexes activate complement, platelet secretion of
12:00 AM | November 30, -0001Author: Adeleke
CXCL-8 which attracts neutrophils and macrophages to the site. These cells may exocytose their granule contents and release reactive oxygen and nitrogen intermediates to cause local tissue damageContinue reading
-
23. Serum sickness
12:00 AM | November 30, -0001Author: Adeleke
occur 7-10 days after injectionContinue reading
-
24. Stevens-Johnson syndrome (SJS)
12:00 AM | November 30, -0001Author: Adeleke
caused by a type 4 HSR to haptenized drugsContinue reading
-
25. IgE-mediated reactions occur within 5-30 minutes
12:00 AM | November 30, -0001Author: Adeleke
(Type I)Continue reading
-
26. Immune complexes cause symptoms after 12 hours
12:00 AM | November 30, -0001Author: Adeleke
(Type III); Arthus reactions..Continue reading
-
27. T cell-mediated reactions develop 2 to 3 days after re-exposure
12:00 AM | November 30, -0001Author: Adeleke
(Type IV).Continue reading